KAM
ABBV icon

KEB Asset Management’s AbbVie ABBV Stock Holding History

KEB Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$540K Buy
2,146
+752
+54% +$162K 0.09% 66
2026
Q1 		$303K Sell
1,394
-396
-22% -$87.8K 0.06% 86
2025
Q4 		$409K Buy
1,790
+58
+3% +$13.2K 0.08% 71
2025
Q3 		$401K Buy
1,732
+21
+1% +$4.28K 0.09% 67
2025
Q2 		$318K Sell
1,711
-79
-4% -$14.7K 0.08% 72
2025
Q1 		$375K Sell
1,790
-83
-4% -$16.1K 0.11% 57
2024
Q4 		$333K Buy
1,873
+241
+15% +$44.3K 0.1% 58
2024
Q3 		$322K Sell
1,632
-392
-19% -$73.2K 0.1% 59
2024
Q2 		$347K Buy
2,024
+4
+0.2% +$663 0.12% 52
2024
Q1 		$368K Buy
2,020
+5
+0.2% +$862 0.13% 47
2023
Q4 		$312K Sell
2,015
-853
-30% -$124K 0.12% 50
2023
Q3 		$428K Sell
2,868
-51
-2% -$7.49K 0.18% 35
2023
Q2 		$393K Buy
2,919
+1,609
+123% +$236K 0.16% 36
2023
Q1 		$209K Hold
1,310
– – 0.09% 56
2022
Q4 		$212K Buy
+1,310
New +$201K 0.11% 56
2022
Q3 		– Sell
-1,310
Closed -$201K – 55
2022
Q2 		$201K Buy
+1,310
New +$200K 0.13% 53

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

KEB Asset Management's ABBV Position: Q2 2026 in Review

KEB Asset Management increased its AbbVie (ABBV) stake by 54% in Q2 2026, buying an estimated $162K and bringing the position to 2,146 shares worth $540K. The position accounts for 0.09% of the portfolio, ranked #66.

KEB Asset Management first reported a position in ABBV in Q2 2022 and has held it in 16 quarters since. 926 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • KEB Asset Management held 2,146 shares of AbbVie worth $540K as of Q2 2026.
  • KEB Asset Management bought 752 AbbVie shares in Q2 2026, an estimated $162K.
  • AbbVie made up 0.09% of KEB Asset Management's portfolio in Q2 2026, its #66 holding.
  • KEB Asset Management first reported a position in AbbVie in Q2 2022 and has held it in 16 quarters since.
  • 926 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on KEB Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.